Alumis to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

GlobeNewswireNov 4 08:00 ET

Alumis Initiated at Outperform by Baird

Dow JonesOct 31 06:08 ET · Ratings

Baird Initiates Alumis(ALMS.US) With Buy Rating, Announces Target Price $25

Moomoo NewsOct 30 17:32 ET · Ratings

Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside

BenzingaOct 17 14:32 ET

This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

BenzingaOct 17 09:05 ET

Express News | Alumis Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $30

ReutersOct 17 06:05 ET